ShardaCare Healthcity has announced the launch of High-Dose-Rate (HDR) Brachytherapy Unit. This technology aims to deliver precision-driven, patient-centric cancer care through cutting-edge innovation ...
UCLA scientists, together with a team of international collaborators, have identified a promising new treatment strategy that ...
A simultaneous or sequential combination of brentuximab vedotin and radiotherapy is feasible and well tolerated in patients ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced new research from more than 100 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results